Reuters logo
BRIEF-Sinclair IS Pharma sees H1 revenue up 4 pct
January 10, 2013 / 7:16 AM / 5 years ago

BRIEF-Sinclair IS Pharma sees H1 revenue up 4 pct

LONDON, Jan 10 (Reuters) - Sinclair IS Pharma PLC : * Revenues for the first half expected to be approximately £23.0 million, +4%

like-for like * Expects adjusted EBITDA to exceed the profit of £0.7 million in same period

year ago * Confident in the outlook for the full year

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below